Type:Notice
Citation:89 FR 99827
Reading Time:less than a minute
Boehringer Ingelheim Animal Health Puerto Rico LLC submitted a notification for proposed production at their facility in Barceloneta, Puerto Rico, within Subzone 61AC. The notification was reviewed by the Foreign-Trade Zones Board, which published an invitation for public comment in the Federal Register on August 14, 2024. On December 6, 2024, the Board decided that no further review was needed and authorized the production activity as described, following their regulations. The decision is noted in Federal Register document number 2024-29086.
Simple Explanation
Boehringer Ingelheim Animal Health Puerto Rico got permission to make animal medicine in Barceloneta, Puerto Rico, after officials checked and said it was okay to start without more reviews.